Author: Liu Y1,2, Bloom SI3, Donato AJ1,3,4,5
1Department of Internal Medicine, University of Utah, Salt Lake City, Utah.
2Department of Geriatrics, Tongji Hospital of Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
3Department of Nutrition and Integrative Physiology, University of Utah, Salt Lake City, Utah.
4Department of Biochemistry, University of Utah, Salt Lake City, Utah.
5Geriatrics Research Education and Clinical Center, Veteran's Affairs Medical Center, Salt Lake City, Utah.
Date published: 2018 Jun 20
Other: Volume ID: e12487 , Special Notes: doi: 10.1111/micc.12487. [Epub ahead of print] , Word Count: 213
In the United States and other westernized nations, cardiovascular diseases (CVDs) are the leading cause of death in adults over 65 years of age. Large artery stiffness and endothelial dysfunction are increased with age and age-associated arterial dysfunction is an important antecedent of CVDs. One age-associated change that may contribute to vascular dysfunction and CVD risk is an increase in the number of resident senescence cells in the vasculature. Senescent cells display a pro-oxidant, pro-inflammatory phenotype known as the senescence associated secretory phenotype (SASP). However, the mechanisms that drive the SASP and the vascular aging phenotype remain elusive. A putative mechanism is the involvement of oxidative stress and inflammation in telomere function. Telomeres are the end caps of chromosomes which are maintained by a six-protein complex known as shelterin. Disruption of shelterin can uncap telomeres and induce cellular senescence. Accordingly, in this review we propose that oxidative stress and inflammation disrupt shelterin in vascular cells, driving telomere dysfunction and that this mechanism may be responsible for the induction of SASP. The proposed mechanisms may represent some of the initial changes that lead to vascular dysfunction in advanced age. This article is protected by copyright. All rights reserved.
KEYWORDS: Aging; Cardiovascular Disease; Endothelium; Inflammation; Large Artery Stiffness; Oxidative Stress; Senescence; Shelterin; Telomere
PMID: 29924435 DOI: 10.1111/micc.12487